Home » Bespak to Cut Jobs as Exubera Prospect Falls Short
Bespak to Cut Jobs as Exubera Prospect Falls Short
Bespak, one of the two contract manufacturers of Pfizer’s inhaled insulin Exubera, has announced it will cut a “significant” number of jobs as sales of the once-touted blockbuster are falling short of expectations.
Outsourcing-Pharma.com
Upcoming Events
-
07May
-
14May
-
30May